project id: TCGA-HNSC; case submitter id: TCGA-P3-A5QA; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 2.0; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.39; rna integrity number: 7.9; age at index: 41; days to birth: -15125; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1967; age at diagnosis: 15125; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage II; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage I; ajcc pathologic t: T1; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2182.0; icd 10 code: C02.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Tongue, NOS; synchronous malignancy: No; tissue or organ of origin: Tongue, NOS; tumor grade: Not Reported; year of diagnosis: 2008; alcohol history: Yes; is ffpe: false; weight: 10.0; composition: Not Reported; days to collection: 1596; days to sample procurement: 0; initial weight: 20.0; portion submitter id: TCGA-P3-A5QA-01A-11; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 50.0; percent tumor cells: 50.0; percent tumor nuclei: 60.0;